JANE STREET GROUP, LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 66 filers reported holding CTI BIOPHARMA CORP in Q1 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$1,385,038
+188.3%
329,771
+312.5%
0.00%
Q4 2022$480,415
-78.4%
79,936
-79.1%
0.00%
-100.0%
Q3 2022$2,227,000
+99.2%
382,686
+104.2%
0.00%
Q2 2022$1,118,000
-31.6%
187,403
-46.5%
0.00%
Q1 2022$1,635,000
+514.7%
350,283
+226.0%
0.00%
Q4 2021$266,000
+421.6%
107,449
+520.4%
0.00%
Q3 2021$51,000
+54.5%
17,319
+11.6%
0.00%
Q3 2020$33,000
-72.3%
15,519
-88.8%
0.00%
Q2 2019$119,000
+1222.2%
138,330
+998.5%
0.00%
Q4 2018$9,000
-98.1%
12,593
-92.9%
0.00%
-100.0%
Q4 2017$472,000
+102.6%
176,171
+218.0%
0.00%0.0%
Q1 2017$233,00055,3930.00%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q1 2018.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders